Market research
200028.SHE China National Accord Medicines Corporation Ltd
SHE HKD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 7B
- P/E ratio
- 5.84
- Analyst target
- 47.54
- Dividend yield
- 4.7%
- Beta
- 0.1
Community
Investor discussion
1 comment
Sign in to join the 200028.SHE discussion.
5 years, 5 months ago
China National Accord Medicines Corporation Ltd is currently in a long term uptrend where the price is trading 1.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
China National Accord Medicines Corporation Ltd's total revenue rose by 27.3% to $17B since the same quarter in the previous year.
Its net income has increased by 30.8% to $404M since the same quarter in the previous year.
Finally, its free cash flow fell by 169.3% to $-586M since the same quarter in the previous year.
Based on the above factors, China National Accord Medicines Corporation Ltd gets an overall score of 4/5.